1. Home
  2. INTS vs BTCT Comparison

INTS vs BTCT Comparison

Compare INTS & BTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • BTCT
  • Stock Information
  • Founded
  • INTS 2012
  • BTCT 2006
  • Country
  • INTS United States
  • BTCT China
  • Employees
  • INTS N/A
  • BTCT N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • BTCT Other Consumer Services
  • Sector
  • INTS Health Care
  • BTCT Real Estate
  • Exchange
  • INTS Nasdaq
  • BTCT Nasdaq
  • Market Cap
  • INTS 30.8M
  • BTCT 28.3M
  • IPO Year
  • INTS 2023
  • BTCT N/A
  • Fundamental
  • Price
  • INTS $1.30
  • BTCT $4.19
  • Analyst Decision
  • INTS Strong Buy
  • BTCT
  • Analyst Count
  • INTS 3
  • BTCT 0
  • Target Price
  • INTS $8.50
  • BTCT N/A
  • AVG Volume (30 Days)
  • INTS 37.8K
  • BTCT 131.0K
  • Earning Date
  • INTS 05-08-2025
  • BTCT 05-15-2025
  • Dividend Yield
  • INTS N/A
  • BTCT N/A
  • EPS Growth
  • INTS N/A
  • BTCT N/A
  • EPS
  • INTS N/A
  • BTCT N/A
  • Revenue
  • INTS N/A
  • BTCT $8,482,000.00
  • Revenue This Year
  • INTS N/A
  • BTCT $11.07
  • Revenue Next Year
  • INTS N/A
  • BTCT $5.27
  • P/E Ratio
  • INTS N/A
  • BTCT N/A
  • Revenue Growth
  • INTS N/A
  • BTCT N/A
  • 52 Week Low
  • INTS $1.27
  • BTCT $1.32
  • 52 Week High
  • INTS $5.28
  • BTCT $26.58
  • Technical
  • Relative Strength Index (RSI)
  • INTS 22.77
  • BTCT 56.84
  • Support Level
  • INTS $1.78
  • BTCT $3.25
  • Resistance Level
  • INTS $1.94
  • BTCT $3.72
  • Average True Range (ATR)
  • INTS 0.17
  • BTCT 0.43
  • MACD
  • INTS -0.03
  • BTCT 0.09
  • Stochastic Oscillator
  • INTS 4.10
  • BTCT 84.04

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About BTCT BTC Digital Ltd.

BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations.

Share on Social Networks: